Clinical impact of pneumomediastinum in patients with myositis-associated interstitial lung disease.

PLoS One · 2025 · PMC12250632 · PMID 40644484

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

marginally significantp = 0.074so close (0.05 < p ≤ 0.1)

75.0%, p = 0.021), and there was a marginally significant increase in the proportion of patients receiving steroid pulse therapy (27.1% vs. 50.0%, p = 0.074), in the pneumomediastinum group compared with the non-pneumomediastinum group.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.